BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 9284197)

  • 1. Analysis of the local control in lymph-node staged localized prostate cancer treated by external beam radiotherapy, assessed by digital rectal examination, serum prostate-specific antigen and biopsy.
    Borghede G; Aldenborg F; Wurzinger E; Johansson KA; Hedelin H
    Br J Urol; 1997 Aug; 80(2):247-55. PubMed ID: 9284197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen.
    Crook JM; Bahadur YA; Bociek RG; Perry GA; Robertson SJ; Esche BA
    Cancer; 1997 Jan; 79(2):328-36. PubMed ID: 9010106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
    Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate brachytherapy: treatment strategies.
    Stone NN; Stock RG
    J Urol; 1999 Aug; 162(2):421-6. PubMed ID: 10411050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma.
    Ragde H; Elgamal AA; Snow PB; Brandt J; Bartolucci AA; Nadir BS; Korb LJ
    Cancer; 1998 Sep; 83(5):989-1001. PubMed ID: 9731904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.
    Fitch DL; McGrath S; Martinez AA; Vicini FA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1430-9. PubMed ID: 16765527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
    Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
    Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.
    Scattoni V; Roscigno M; Raber M; Montorsi F; Da Pozzo L; Guazzoni G; Freschi M; Rigatti P
    Eur Urol; 2003 Oct; 44(4):407-14. PubMed ID: 14499673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transrectal ultrasonically-guided core biopsies in the assessment of local cure of prostatic cancer after radical external beam radiotherapy.
    Ljung G; Norberg M; Hansson H; de la Torre M; Egevad L; Holmberg L; Busch C; Nilsson S
    Acta Oncol; 1995; 34(7):945-52. PubMed ID: 7492386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen spikes after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):450-6. PubMed ID: 12243821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
    Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
    Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial.
    Dinges S; Deger S; Koswig S; Boehmer D; Schnorr D; Wiegel T; Loening SA; Dietel M; Hinkelbein W; Budach V
    Radiother Oncol; 1998 Aug; 48(2):197-202. PubMed ID: 9783892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
    Zagars GK
    J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation.
    Stokes SH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):129-36. PubMed ID: 10758314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical dose escalation by high-dose-rate brachytherapy for localized prostate cancer-Significance of prostate-specific antigen nadir level within 18 months as correlation for long-term biochemical control.
    Schroeder C; Geiger F; Siebert FA; Baumann R; Bockelmann G; Schultze J; Kimmig B; Dunst J; Galalae R
    Brachytherapy; 2019; 18(1):8-12. PubMed ID: 30482622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.
    Pollack A; Zagars GK; Antolak JA; Kuban DA; Rosen II
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):677-85. PubMed ID: 12377318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: is lymph node sampling necessary?
    Kovács G; Galalae R
    Cancer Radiother; 2003 Apr; 7(2):100-6. PubMed ID: 12719039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
    Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
    Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.